Nektar Therapeutics Inc (NKTR) President & CEO Howard W Robin Sold $3.1 million of Shares
President & CEO of Nektar Therapeutics Inc (30-Year Financial, Insider Trades) Howard W Robin (insider trades) sold 100,000 shares of NKTR on 07/25/2019 at an average price of $31.29 a share. The total sale was $3.1 million.
Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company is researching and developing drugs for treating cancer, auto-immune disease and chronic pain. Nektar Therapeutics Inc has a market cap of $5.23 billion; its shares were traded at around $29.99 with a P/E ratio of 8.53 and P/S ratio of 4.60. GuruFocus has detected 2 severe warning signs with Nektar Therapeutics Inc. .
CEO Recent Trades:
President & CEO Howard W Robin sold 100,000 shares of NKTR stock on 07/25/2019 at the average price of $31.29. The price of the stock has decreased by 4.15% since.
CFO Recent Trades:
SVP & CFO Gil M Labrucherie sold 25,000 shares of NKTR stock on 07/10/2019 at the average price of $34.57. The price of the stock has decreased by 13.25% since.
Directors and Officers Recent Trades:
Director Lutz Lingnau sold 10,000 shares of NKTR stock on 07/08/2019 at the average price of $34.63. The price of the stock has decreased by 13.4% since.
For the complete insider trading history of NKTR, click here
.This article first appeared on GuruFocus.
